A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
Clinical trial NCT02075840 · COMPLETED
Trial details
- NCT number
- NCT02075840
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-19
- Primary completion
- 2017-02-09
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.